Hidenobu Tanihara
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Effects of Ripasudil on Mouse Subconjunctival Immune Cell Motility Activated by Monocyte Chemoattractant Protein-1.
Journal: Investigative ophthalmology & visual science
Published: June 11, 2026
Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study.
Journal: Ophthalmology. Glaucoma
Published: November 26, 2024
Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: August 23, 2023
Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.
Journal: Advances in therapy
Published: February 16, 2023
Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials.
Journal: American journal of ophthalmology
Published: June 17, 2022
Elevated soluble vascular endothelial growth factor receptor levels in aqueous humor from patients with different types of glaucoma.
Journal: Experimental eye research
Published: April 19, 2022
Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months.
Journal: Advances in therapy
Published: October 28, 2021
Intraocular Pressure-Lowering Effects of Trabeculectomy Versus MicroShunt Insertion in Rabbit Eyes.
Journal: Translational vision science & technology
Published: August 06, 2021
Factors associated with the surgical outcomes of Baerveldt glaucoma implant for open-angle glaucoma, an age-related eye disease.
Journal: Scientific reports
Published: July 25, 2021
Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance.
Journal: The Journal of biological chemistry
Published: February 26, 2021
Potential roles of the IL-6 family in conjunctival fibrosis.
Journal: Experimental eye research
Published: November 16, 2020
Last Updated: 09/26/2026